Finance

Beta
Lists
Q1 2026 earnings • released • EPS miss -13.50% • Revenue miss -6.52%
See results
IHH:KLSE
IHH Healthcare Bhd
MYR 8.85
+0.68%
(+0.060) 1D
Jun 5, 5:00:00 PM GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for IHH...
Open
MYR 8.79
High
MYR 8.88
Low
MYR 8.72
Mkt. cap
78.20B
Avg. vol.
8.72M
Volume
2.78M
Dividend
1.19%
Quarterly dividend
MYR 0.03
Ex-dividend date
Mar 27, 2026
P/E ratio
36.97
52-wk high
MYR 10.48
52-wk low
MYR 6.42
EPS
MYR 0.24
Shares outstanding
8.84B
No. of employees
76K
Open
MYR 8.79
High
MYR 8.88
Low
MYR 8.72
Mkt. cap
78.20B
Avg. vol.
8.72M
Volume
2.78M
Dividend
1.19%
Quarterly dividend
MYR 0.03
Ex-dividend date
Mar 27, 2026
P/E ratio
36.97
52-wk high
MYR 10.48
52-wk low
MYR 6.42
EPS
MYR 0.24
Shares outstanding
8.84B
No. of employees
76K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to IHH in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for IHH in the last 3 months.
Highest
Current $8.85
$2.64 (-70.15%)
Average
$2.64 (-70.17%)
Lowest
$2.64 (-70.15%)
News stories
From sources across the web
Profile
IHH Healthcare Berhad is an international private healthcare group focused on upmarket health services. It is Asia's largest private healthcare group. It is headquartered in Kuala Lumpur and its geographical footprint crosses Malaysia, Singapore, Turkey, India, Greater China, other parts of Asia and Central and Eastern Europe. The group has over 70,000 employees across 80 hospitals in 10 countries. It is listed on Bursa Malaysia and the Singapore Exchange. As of FY24, the largest shareholder of IHH Healthcare is Mitsui of Japan followed by the Malaysian government's sovereign wealth fund Khazanah Nasional and Citigroup of the United States. A further stake is held by the Employees Provident Fund of Malaysia. The chairman of IHH is Nik Norzrul Thani bin N Hassan Thani. Wikipedia
About IHH Healthcare Bhd
CEOPrem Kumar Nair
Employees76K
Founded1974
Headquarters-
SectorHealth care provider
Last report
Jun 4, 2026
Fiscal period
Q1 2026
EPS / Est. (MYR)
MYR 0.05 / MYR 0.06
-13.50%miss
Revenue / Est. (MYR)
6.55B / 7.01B
-6.52%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in MYR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in MYR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.30B
6.57B
6.58B
6.55B
Cost of goods sold
4.26B
4.33B
4.34B
4.43B
Cost of revenue
4.26B
4.33B
4.34B
4.43B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.00M
34.00M
47.00M
38.00M
Operating expense
1.14B
1.20B
1.26B
1.17B
Total operating expenses
5.40B
5.53B
5.60B
5.60B
Operating income
895.00M
1.04B
983.00M
952.00M
Other non operating income
-4.00M
-10.00M
-21.00M
-11.00M
EBT including unusual items
727.00M
1.05B
886.00M
972.00M
EBT excluding unusual items
715.00M
808.00M
749.00M
743.00M
Income tax expense
160.00M
264.00M
260.00M
297.00M
Effective tax rate
22.01%
25.07%
29.35%
30.56%
Other operating expenses
647.00M
674.00M
621.00M
641.00M
Net income
443.00M
616.00M
528.00M
528.00M
Net profit margin
7.03%
9.38%
8.02%
8.06%
Earnings per share
0.05
0.05
0.06
0.05
Interest and investment income
43.00M
45.00M
39.00M
53.00M
Interest expense
-242.00M
-269.00M
-252.00M
-252.00M
Net interest expenses
-199.00M
-224.00M
-213.00M
-199.00M
Depreciation and amortization charges
447.00M
476.00M
474.00M
466.00M
EBITDA
1.25B
1.40B
1.36B
1.33B
Gain or loss from assets sale
-2.00M
4.00M
-3.00M
-2.00M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more